Literature DB >> 29281813

Loss of Synapse Repressor MDGA1 Enhances Perisomatic Inhibition, Confers Resistance to Network Excitation, and Impairs Cognitive Function.

Steven A Connor1, Ina Ammendrup-Johnsen2, Yasushi Kishimoto3, Parisa Karimi Tari2, Vedrana Cvetkovska2, Takashi Harada3, Daiki Ojima4, Tohru Yamamoto4, Yu Tian Wang5, Ann Marie Craig6.   

Abstract

Synaptopathies contributing to neurodevelopmental disorders are linked to mutations in synaptic organizing molecules, including postsynaptic neuroligins, presynaptic neurexins, and MDGAs, which regulate their interaction. The role of MDGA1 in suppressing inhibitory versus excitatory synapses is controversial based on in vitro studies. We show that genetic deletion of MDGA1 in vivo elevates hippocampal CA1 inhibitory, but not excitatory, synapse density and transmission. Furthermore, MDGA1 is selectively expressed by pyramidal neurons and regulates perisomatic, but not distal dendritic, inhibitory synapses. Mdga1-/- hippocampal networks demonstrate muted responses to neural excitation, and Mdga1-/- mice are resistant to induced seizures. Mdga1-/- mice further demonstrate compromised hippocampal long-term potentiation, consistent with observed deficits in spatial and context-dependent learning and memory. These results suggest that mutations in MDGA1 may contribute to cognitive deficits through altered synaptic transmission and plasticity by loss of suppression of inhibitory synapse development in a subcellular domain- and cell-type-selective manner.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E/I ratio; Neuroligin; hippocampus; inhibitory synapse; memory; neurexin; neurodevelopmental disorders; synapse development; synaptic plasticity

Mesh:

Substances:

Year:  2017        PMID: 29281813     DOI: 10.1016/j.celrep.2017.11.109

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  11 in total

Review 1.  A negative regulator of synaptic development: MDGA and its links to neurodevelopmental disorders.

Authors:  Rui Wang; Jia-Xian Dong; Lu Wang; Xin-Yan Dong; Eitan Anenberg; Pei-Fang Jiang; Ling-Hui Zeng; Yi-Cheng Xie
Journal:  World J Pediatr       Date:  2019-04-17       Impact factor: 2.764

2.  Rare variant based evidence for oligogenic contribution of neurodevelopmental pathway genes to schizophrenia.

Authors:  Jibin John; Prachi Kukshal; Triptish Bhatia; V L Nimgaonkar; S N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2019-01-04       Impact factor: 4.939

3.  Hippocampal Egr1-Dependent Neuronal Ensembles Negatively Regulate Motor Learning.

Authors:  Verónica Brito; Enrica Montalban; Anna Sancho-Balsells; Anika Pupak; Francesca Flotta; Mercè Masana; Silvia Ginés; Jordi Alberch; Claire Martin; Jean-Antoine Girault; Albert Giralt
Journal:  J Neurosci       Date:  2022-05-24       Impact factor: 6.709

4.  MDGAs are fast-diffusing molecules that delay excitatory synapse development by altering neuroligin behavior.

Authors:  Mathieu Letellier; Giorgia Bimbi; Daniel Choquet; Olivier Thoumine; Andrea Toledo; Béatrice Tessier; Sophie Daburon; Alexandre Favereaux; Ingrid Chamma; Kristel Vennekens; Jeroen Vanderlinden; Matthieu Sainlos; Joris de Wit
Journal:  Elife       Date:  2022-05-09       Impact factor: 8.713

5.  IgSF9b regulates anxiety behaviors through effects on centromedial amygdala inhibitory synapses.

Authors:  Olga Babaev; Hugo Cruces-Solis; Carolina Piletti Chatain; Matthieu Hammer; Sally Wenger; Heba Ali; Nikolaos Karalis; Livia de Hoz; Oliver M Schlüter; Yuchio Yanagawa; Hannelore Ehrenreich; Holger Taschenberger; Nils Brose; Dilja Krueger-Burg
Journal:  Nat Commun       Date:  2018-12-20       Impact factor: 14.919

6.  MDGA1 negatively regulates amyloid precursor protein-mediated synapse inhibition in the hippocampus.

Authors:  Jinhu Kim; Seungjoon Kim; Hyeonho Kim; In-Wook Hwang; Sungwon Bae; Sudeep Karki; Dongwook Kim; Roberto Ogelman; Geul Bang; Jin Young Kim; Tommi Kajander; Ji Won Um; Won Chan Oh; Jaewon Ko
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

7.  Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment.

Authors:  Masahisa Matsumura; Kana Sato; Takashi Kubota; Yasushi Kishimoto
Journal:  Data Brief       Date:  2021-05-12

8.  Visually cued fear conditioning test for memory impairment related to cortical function.

Authors:  Kazuya Kuboyama; Yuki Shirakawa; Koji Kawada; Naoki Fujii; Daiki Ojima; Yasushi Kishimoto; Tohru Yamamoto; Maki K Yamada
Journal:  Neuropsychopharmacol Rep       Date:  2020-10-21

9.  Impairment of cerebellar long-term depression and GABAergic transmission in prion protein deficient mice ectopically expressing PrPLP/Dpl.

Authors:  Yasushi Kishimoto; Moritoshi Hirono; Ryuichiro Atarashi; Suehiro Sakaguchi; Tohru Yoshioka; Shigeru Katamine; Yutaka Kirino
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

10.  SALM4 negatively regulates NMDA receptor function and fear memory consolidation.

Authors:  Eunkyung Lie; Yeji Yeo; Eun-Jae Lee; Wangyong Shin; Kyungdeok Kim; Kyung Ah Han; Esther Yang; Tae-Yong Choi; Mihyun Bae; Suho Lee; Seung Min Um; Se-Young Choi; Hyun Kim; Jaewon Ko; Eunjoon Kim
Journal:  Commun Biol       Date:  2021-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.